Physician profile
Grover E May
NPI 1497750657
$916,310.91
in general payments reported to CMS, 2019-2025
32 companies · $149K in 2025
The $149K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $48K · 2021: $231K · 2022: $179K · 2023: $147K · 2024: $125K · 2025: $149K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $205K · Consulting Fee: $159K · Travel and Lodging: $49K · Food and Beverage: $8,331 · Education: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $204,697.22 |
| Consulting Fee | $158,519.39 |
| Travel and Lodging | $48,550.09 |
| Food and Beverage | $8,331.08 |
| Education | $762.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $912,995.59 | 2019-2025 | Gelpoint V-Path, Soft/Traction Clamp Inserts |
| Coopersurgical, INC. | $352.23 | 2019-2021 | |
| Baxter Healthcare | $328.25 | 2020-2021 | |
| Intuitive Surgical, INC. | $310.32 | 2022-2023 | Da Vinci Surgical System |
| Teleflex LLC | $254.22 | 2019-2021 | |
| Abbvie INC. | $241.18 | 2019-2023 | |
| Astellas Pharma US INC | $187.08 | 2023-2025 | Veozah, Myrbetriq |
| Momentis Surgical INC. | $178.67 | 2021 | |
| Mayne Pharma Commercial LLC | $168.43 | 2022-2025 | |
| Conmed Corporation | $155.73 | 2019 | |
| Sumitomo Pharma America, INC. | $135.39 | 2023-2025 | Myfembree, Gemtesa |
| Asensus Surgical, INC. | $99.82 | 2019 | |
| Boston Scientific Corporation | $97.35 | 2025 | General - Female Sui |
| Daiichi Sankyo INC. | $96.68 | 2019-2024 | Injectafer |
| Myovant Sciences INC. | $78.05 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $76.06 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $74.09 | 2019-2025 | |
| Aspira Women'S Health INC | $58.78 | 2022 | |
| Dilon Technologies, INC. | $55.23 | 2023 | Hemoblast Bellows |
| Avion Pharmaceuticals | $52.89 | 2019 | |
| Urovant Sciences INC | $46.66 | 2022 | |
| Organon LLC | $45.57 | 2022-2024 | Nexplanon |
| Therapeuticsmd, INC. | $42.46 | 2019-2020 | |
| Allergan, INC. | $34.99 | 2019 | |
| Pfizer INC. | $28.73 | 2024-2025 | |
| Lupin INC. | $23.22 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $23.03 | 2019 | |
| Novo Nordisk INC | $16.23 | 2023 | Wegovy |
| Caldera Medical, INC | $15.94 | 2025 | |
| Amgen INC. | $14.56 | 2019 | |
| Evofem Biosciences, INC. | $12.24 | 2021 | |
| Olympus America INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grover May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.